| Net income | -80.6M |
| Depreciation and amortization | |
| Loss on redemption of debt | |
| Foreign exchange gain | |
| Deferred income taxes | |
| Excess tax benefits from share-based payment arrangements | |
| Long lived impairment charges and loss on sale of assets | |
| Stock based compensation | |
| Other non-cash items | -3.8M |
| Change in operating assets, liabilities and other | |
| Net cash (used in) provided by operating activities | -6.2M |
| Capital expenditures | -119.6M |
| Proceeds from sale of property, plant and equipment | 11.5M |
| Acquisition, net of cash acquired | |
| Net cash used in investing activities | -81.3M |
| Repayments on ABL revolver | |
| Borrowings on ABL revolver | |
| Repayment of long-term debt | -1.7M |
| Fees paid to amend or issue debt facilities and equity | |
| Excess tax benefits from share-based payment arrangements | |
| Stock compensation plan activity | |
| Net cash provided by financing activities | -47.5M |
| Effect of exchange rate changes on cash and cash equivalents | 5.4M |
| Net change in cash and cash equivalents | -129.6M |
| Cash and cash equivalents at beginning of period | 258M |
| Cash and cash equivalents at end of period | 128.4M |